Skip to main content Skip to navigation

Research Exchange

Implications of PARP1 in myelodysplastic syndromes and targeted therapy

Type

grant

Grant Number

R01 HL163011

A global leader in the fight against gynecologic cancer

LIVING LAB

Join the Living Lab Our Team Governance & Ethics Shareable Resources

DISCOVERY LAB

Discovery Lab How It Works Upcoming Webinars Contribute Data

ABOUT

About OCRA Get Involved Make a Donation Contact Us

© 2025 Ovarian Cancer Research Alliance, Inc.

Privacy Terms Accessibility

Implications of PARP1 in myelodysplastic syndromes and targeted therapy